ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22 | -8.3% | 15,000 | 0.0% | 0.01% | -7.1% |
| Q2 2023 | $24 | +118.2% | 15,000 | 0.0% | 0.01% | +133.3% |
| Q1 2023 | $11 | +22.2% | 15,000 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $9 | -99.9% | 15,000 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $14,000 | -22.2% | 15,000 | 0.0% | 0.01% | -18.2% |
| Q2 2022 | $18,000 | -10.0% | 15,000 | 0.0% | 0.01% | +10.0% |
| Q1 2022 | $20,000 | -23.1% | 15,000 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $26,000 | -21.2% | 15,000 | 0.0% | 0.01% | -29.4% |
| Q3 2021 | $33,000 | -36.5% | 15,000 | 0.0% | 0.02% | -37.0% |
| Q2 2021 | $52,000 | – | 15,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |